- Our Doctors
- Dr Lucy Corke
Dr Lucy Corke
BSc, MBBS, FRACP, Medical Oncologist
Languages spoken
English
Overview
Centres
Clinical interests
Clinical interest in lung cancer, brain cancer, genitourinary & gynaecological cancer
Dr Lucy Corke is a medical oncologist joining the team at GenesisCare Maitland and is a staff specialist at the Calvary Mater Newcastle.
After completing her training in Queensland, she undertook a clinical research fellowship in Thoracic Oncology at the Princess Margaret Cancer Centre in Toronto, Canada. During this time she was heavily involved in clinical trials, as well as research involving the use of liquid biopsies in lung cancer.
Since returning to Australia and relocating to Newcastle, she has expanded her clinical interests to include the management of patients with brain cancer, genitourinary cancers (prostate, bladder, kidney) and gynaecologic cancers (ovary, uterus).
Lucy is passionate about providing high-quality, personalised and holistic care to her patients while working within a collaborative multi-disciplinary team.
In her spare time, Lucy likes ocean swims and yoga and encourages her patients to enjoy these too.
Professional memberships
- Thoracic Oncology Group of Australia (TOGA)
- Cooperative Trials Group for Neuro-Oncology (COGNO)
- Australia New Zealand Gynaecological Group of Australia (ANZGOG)
- International Association for the Study of Lung Cancer (IASLC)
- Medical Oncology Group of Australia (MOGA)
- European Society of Medical Oncology (ESMO)
Publications
Corke, L., & Sacher, A. (2021). New strategies and combinations to improve outcomes in Immunotherapy in metastatic non-small-cell lung cancer. Current Oncology, 29(1), 38-55.
Corke, L. K., Li, J. J., Leighl, N. B., & Eng, L. (2022). Tobacco use and response to immune checkpoint inhibitor therapy in non-small cell lung cancer. Current Oncology, 29(9), 6260-6276.
Alghabban, A., Corke, L., Katzberg, H., Bril, V., Barnett-Tapia, C., Mason, W., ... & Shepherd, F. A. (2024). MYASTHENIA GRAVIS IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS. JTO Clinical and Research Reports, 100772.
García-Pardo, M., Czarnecka-Kujawa, K., Law, J. H., Salvarrey, A. M., Fernandes, R., Fan, Z. J., ... & Leighl, N. B. (2023). Association of circulating tumor DNA testing before tissue diagnosis with time to treatment among patients with suspected advanced lung cancer: the accelerate nonrandomized clinical trial. JAMA network open, 6(7), e2325332-e2325332..
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.